Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intec Pharma Ord Shr (NTEC)

Intec Pharma Ord Shr (NTEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,845
  • Shares Outstanding, K 71,839
  • Annual Sales, $ 0 K
  • Annual Income, $ -47,600 K
  • 60-Month Beta 0.77
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.04
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.55
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/10/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +84.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2215 +12.14%
on 09/04/20
0.3249 -23.55%
on 08/26/20
-0.0416 (-14.34%)
since 08/25/20
3-Month
0.2215 +12.14%
on 09/04/20
0.7908 -68.59%
on 07/22/20
-0.0676 (-21.39%)
since 06/25/20
52-Week
0.1324 +87.61%
on 03/18/20
0.8800 -71.77%
on 09/30/19
-0.5513 (-68.94%)
since 09/25/19

Most Recent Stories

More News
Intec Pharma to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

, /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the virtual Oppenheimer Fall Healthcare Life Sciences & MedTech...

MHMNF : 54.5000 (unch)
NTEC : 0.2484 (+2.18%)
Intec Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference

, /PRNewswire/ --Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the virtual H.C. Wainwright 22 Annual Global Investment Conference....

NTEC : 0.2484 (+2.18%)
Thinking about buying stock in Heat Biologics, Co-Diagnostics, Penn National Gaming, Boxlight Corp, or Intec Pharma?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HTBX, CODX, PENN, BOXL, and NTEC.

BOXL : 1.6600 (+14.48%)
HTBX : 1.2800 (+3.23%)
NTEC : 0.2484 (+2.18%)
PENN : 69.85 (+9.17%)
Intec Pharma Announces Pricing of $4.9 Million Registered Direct Offering

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company"), today announced that it has entered into a definitive agreement with Aspire Capital Fund ("Aspire") for the purchase and sale, in a registered...

NTEC : 0.2484 (+2.18%)
Intec Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update

, /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the second quarter ended and provides a corporate update. 

NTEC : 0.2484 (+2.18%)
Intec Pharma Ltd. (NTEC) Upgraded to Strong Buy: Here's Why

Intec Pharma Ltd. (NTEC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

NTEC : 0.2484 (+2.18%)
Implied Volatility Surging for Intec Pharma (NTEC) Stock Options

Investors need to pay close attention to Intec Pharma (NTEC) stock based on the movements in the options market lately.

NTEC : 0.2484 (+2.18%)
Intec Pharma to Present at Jefferies Virtual Healthcare Conference

, /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will present at the Jefferies Virtual Healthcare Conference.

NTEC : 0.2484 (+2.18%)
Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update

, /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the first quarter ended and provides a corporate update. 

NTEC : 0.2484 (+2.18%)
Intec Pharma Announces $5.0 Million Registered Direct Offering

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company"), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale...

NTEC : 0.2484 (+2.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NTEC with:

Business Summary

Intec Pharma Ltd. is a biopharmaceutical company. The company focused on developing drugs through proprietary Accordion Pill platform technology. Its product candidates in clinical trial stages consists of Accordion Pill Carbidopa/Levodopa developed for the indication of treatment of Parkinson's disease...

See More

Key Turning Points

2nd Resistance Point 0.2636
1st Resistance Point 0.2560
Last Price 0.2484
1st Support Level 0.2354
2nd Support Level 0.2224

See More

52-Week High 0.8800
Fibonacci 61.8% 0.5944
Fibonacci 50% 0.5062
Fibonacci 38.2% 0.4180
Last Price 0.2484
52-Week Low 0.1324

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar